Joy Zhou

Dr. Joy Zhou is the Vice President, Head of CMC at MiNK Therapeutics to oversee the company’s CMC operations. She brings 20 years of biologics and cell therapy product development industry experience to advance pre-clinical candidates through clinical development to commercialization as well as post-commercial global expansion. Prior to joining MiNK, Dr. Zhou was Head of MSAT at Rubius Therapeutics. Dr. Zhou also served as various leadership positions through her industry journey at Pfizer, JNJ and Takeda including as the Head of Takeda Cell Therapy Product Development. She received her Ph.D in Pharmaceutical Chemistry from the University of Kansas.